Tarlatamab for Large Cell Neuroendocrine Carcinoma in a Young Adult: A Case Report.
JTO Clin Res Rep
; 5(10): 100712, 2024 Oct.
Article
en En
| MEDLINE
| ID: mdl-39309421
ABSTRACT
A 20-year-old man with metastatic large cell neuroendocrine carcinoma of the lung was treated with the delta-like ligand 3-targeting bispecific T cell engager, tarlatamab. Treatment was complicated by transient cytokine release syndrome but resulted in a partial response. Bispecific T cell engagers may offer a novel treatment approach for large cell neuroendocrine carcinoma of the lung.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
JTO Clin Res Rep
Año:
2024
Tipo del documento:
Article
Pais de publicación:
Estados Unidos